Value of plasma neutrophil extracellular traps on illness condition and prognosis in patients with acute cerebral infarction

LIU Fang; WANG Xiaobei

doi:10.7619/jcmp.20232055

Journal of Clinical Medicine in Practice > 2023 > 27(17): 127-132. > DOI: 10.7619/jcmp.20232055

LIU Fang, WANG Xiaobei. Value of plasma neutrophil extracellular traps on illness condition and prognosis in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2023, 27(17): 127-132. DOI: 10.7619/jcmp.20232055

Citation:

PDF (1168 KB)

Value of plasma neutrophil extracellular traps on illness condition and prognosis in patients with acute cerebral infarction

LIU Fang¹,
WANG Xiaobei²

1.
Laboratory Department, the Second Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830063
2.
Department of Neurology, the Second Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830063

More Information

Received Date: June 26, 2023
Revised Date: August 07, 2023
Available Online: September 18, 2023

Graphical Abstract

Abstract

Abstract

Objective
To analyze correlations of the main components of neutrophil extracellular traps (NETs)[citrulline histone 3 (CitH3) and double-stranded DNA (dsDNA)] with the ill severity in patients with acute cerebral infarction (ACI)and its predictive value in prognosis.
Methods
A total of 120 patients with ACI were collected as study objects, and were divided into mild group[65 cases, the National Institutes of Health Stroke Scale (NIHSS) score of 0 to 4] and severe group (55 cases, the NIHSS score of 4 to 15) according to severity of illness. Before and after treatment, plasma CitH3, dsDNA, N-terminal B-type natriuretic peptide (NT-proBNP), platelet (PLT), prothrombin time (PT), international standardized ratio (INR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-high density lipoprotein cholesterol ratio(MHR) and modified Edinburgh-Scandinavian Stroke Scale (MESSS) score were detected in two groups, and the correlations of above clinical indexes with the NIHSS scores were analyzed. According to the modified Rankin Scale score at the last follow-up, the patients were divided into good prognosis group (98 cases) and poor prognosis group (22 cases). The difference of clinical indicators between the two groups was compared, and the correlations of clinical indicators with poor prognosis of ACI patients were analyzed. Receiver operating characteristic (ROC) curve was drawn to analyze the diagnostic performance of plasma CitH3 combined with dsDNA for the prognosis of ACI patients.
Results
The levels of CitH3, dsDNA, NT-proBNP, MHR and MESSS before and after the treatment in the severe group were all higher than those in the mild group (P<0.05), but the levels of PLT, PT, INR, NLR and PLR showed no significant differences between two groups (P>0.05). The positive correlation of the indexes of CitH3, dsDNA and NT-proBNP with the NIHSS scores were found (r=0.814, 0.775, 0.725; P<0.05). After 1-year follow-up, the levels of plasma CitH3, dsDNA and NT-proBNP in the poor prognosis group were higher than those in the good prognosis group(P<0.05). The increased CitH3 and dsDNA were the risk factors to the short-term poor prognosis in patients with ACI (OR=2.913, P=0.029; OR=2.887, P=0.036). The area under the curve of plasma CitH3 combined with plasma dsDNA in predicting poor prognosis of ACI patients at 1 year follow-up was 0.823, sensitivity was 84.5%, and specificity was 89.5%.
Conclusion
The combined detection of main components of CitH3 and dsDNA of plasma NETs can effectively evaluate the ill severity of patients with ACI, and has good predictive value of the short-term prognosis.
- acute cerebral infarction,
- neutrophil extracellular traps,
- citrulline histone 3,
- double-stranded DNA,
- prognosis

FullText(HTML)

References (18)

References

[1]	MUN K T, HINMAN J D. Inflammation and the link to vascular brain health: timing is brain[J]. Stroke, 2022, 53(2): 427-436. doi: 10.1161/STROKEAHA.121.032613
[2]	KIM S W, DAVAANYAM D, SEOL S I, et al. Adenosine triphosphate accumulated following cerebral ischemia induces neutrophil extracellular trap formation[J]. Int J Mol Sci, 2020, 21(20): 7668. doi: 10.3390/ijms21207668
[3]	BERNIS M E, ZWEYER M, MAES E, et al. Neutrophil extracellular traps release following hypoxic-ischemic brain injury in newborn rats treated with therapeutic hypothermia[J]. Int J Mol Sci, 2023, 24(4): 3598. doi: 10.3390/ijms24043598
[4]	KIM E, CHO S. CNS and peripheral immunity in cerebral ischemia: partition and interaction[J]. Exp Neurol, 2021, 335: 113508. doi: 10.1016/j.expneurol.2020.113508
[5]	WU X Y, ZENG H H, CAI L X, et al. Role of the extracellular traps in central nervous system[J]. Front Immunol, 2021, 12: 783882. doi: 10.3389/fimmu.2021.783882
[6]	中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组, 彭斌, 等. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682. doi: 10.3760/cma.j.issn.1006-7876.2018.09.004
[7]	WANG C Y, LIN T T, HU L, et al. Neutrophil extracellular traps as a unique target in the treatment of chemotherapy-induced peripheral neuropathy[J]. EBioMedicine, 2023, 90: 104499. doi: 10.1016/j.ebiom.2023.104499
[8]	XU X B, WU Y T, XU S X, et al. Clinical significance of neutrophil extracellular traps biomarkers in thrombosis[J]. Thromb J, 2022, 20(1): 63. doi: 10.1186/s12959-022-00421-y
[9]	PIR G J, PARRAY A, AYADATHIL R, et al. Platelet-neutrophil association in NETs-rich areas in the retrieved AIS patient thrombi[J]. Int J Mol Sci, 2022, 23(22): 14477. doi: 10.3390/ijms232214477
[10]	PUY L, CORSEAUX D, PERBET R, et al. Neutrophil extracellular traps (NETs) infiltrate haematoma and surrounding brain tissue after intracerebral haemorrhage: a post-mortem study[J]. Neuropathol Appl Neurobiol, 2021, 47(6): 867-877. doi: 10.1111/nan.12733
[11]	WANG R R, ZHU Y B, LIU Z W, et al. Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke[J]. Blood, 2021, 138(1): 91-103. doi: 10.1182/blood.2020008913
[12]	WILDE M D, DESENDER L, TERSTEEG C, et al. Spatiotemporal profile of neutrophil extracellular trap formation in a mouse model of ischemic stroke[J]. Res Pract Thromb Haemost, 2023, 7(1): 100028. doi: 10.1016/j.rpth.2022.100028
[13]	ZHOU J R, GUO P W, HAO X K, et al. Neutrophil extracellular traps (NETs): a new therapeutic target for neuroinflammation and microthrombosis after subarachnoid hemorrhage[J]. Transl Stroke Res, 2023, 14(4): 443-445. doi: 10.1007/s12975-022-01039-y
[14]	ZHAO Z Y, PAN Z R, ZHANG S, et al. Neutrophil extracellular traps: a novel target for the treatment of stroke[J]. Pharmacol Ther, 2023, 241: 108328. doi: 10.1016/j.pharmthera.2022.108328
[15]	ZHANG S Q, CAO Y Z, DU J W, et al. Neutrophil extracellular traps contribute to tissue plasminogen activator resistance in acute ischemic stroke[J]. FASEB J, 2021, 35(9): e21835. doi: 10.1096/fj.202100471RR
[16]	LARCO J A, ABBASI M, MADHANI S I, et al. Correlation of neutrophil to lymphocyte ratio with expression of neutrophil extracellular traps within stroke emboli[J]. Interv Neuroradiol, 2022, 28(6): 726-730. doi: 10.1177/15910199211065530
[17]	DENORME F, PORTIER I, RUSTAD J L, et al. Neutrophil extracellular traps regulate ischemic stroke brain injury[J]. J Clin Invest, 2022, 132(10): e154225. doi: 10.1172/JCI154225
[18]	HAO X K, ZENG Z W, LIANG L, et al. The role of neutrophil extracellular traps in early microthrombosis and brain injury after subarachnoid hemorrhage in mice[J]. Transl Stroke Res, 2023, 14(5): 752-765. doi: 10.1007/s12975-022-01074-9

[1]	MING Ni, LIU Zhi, WU Haihui, ZHANG Guigui, LIU Lihua. Comparison of magnesium sulfate and nifedipineon hemodynamics and pregnancy outcomes of pregnant woman with hypertensive disorders complicating pregnancy[J]. Journal of Clinical Medicine in Practice, 2022, 26(14): 84-87. DOI: 10.7619/jcmp.20221234
[2]	QIU Yongjun, WANG Fang, QIU Zaijun. Predictive model of adverse reactions of initial application of magnesium sulfate injection in patients with threatened abortion or premature delivery[J]. Journal of Clinical Medicine in Practice, 2022, 26(9): 63-67. DOI: 10.7619/jcmp.20214753
[3]	GUO Haiyan, YANG Haoran, SHI Huilian, LIU Lina, CHE Junyong. Magnesium isoglycyrrhizinate versus compound glycyrrhizin in treatment of patients with non-alcoholic fatty liver disease[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 36-39. DOI: 10.7619/jcmp.20211632
[4]	LYU Xin, ZHANG Xiangjun. Effect of somatostatin combined with magnesium sulfate in treatment of severe acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 28-31. DOI: 10.7619/jcmp.202022008
[5]	XU Jingning, XU Lin, LIU Jinjun. Effect of labetalol combined with magnesium sulfate in the treatment of pregnancy-induced hypertension and its effect on outcomes of childbirth[J]. Journal of Clinical Medicine in Practice, 2020, 24(20): 87-89,93. DOI: 10.7619/jcmp.202020024
[6]	YANG Jing, YANG Yongkang, ZHANG Miaofang, LIU Pei. Effects of magnesium sulfate monotherapy and its combination with labetalol on hemorheological parameters in patients with pregnancy-induced hypertension[J]. Journal of Clinical Medicine in Practice, 2020, 24(4): 45-49. DOI: 10.7619/jcmp.202004011
[7]	ZHONG Yuquan, ZHANG Xu. Influence of magnesium sulfate on levels of serum C-reactive protein, bilirubin and gastrointestinal function in patients with calculous cholecystitis[J]. Journal of Clinical Medicine in Practice, 2016, (23): 40-42,53. DOI: 10.7619/jcmp.201623012
[8]	PAN Xiaojie, LIU Hongxian, LIANG Min. Correction between the serum trace elements,peripheral blood T lymphocyte subsets and children with recurrent respiratory tract infection[J]. Journal of Clinical Medicine in Practice, 2014, (7): 51-53. DOI: 10.7619/jcmp.201407015
[9]	Efficacy and influence of serum IgE of magnesium isoglycyrrhizinate in the treatment of chronic urticaria[J]. Journal of Clinical Medicine in Practice, 2013, (14): 97-98,101. DOI: 10.7619/jcmp.201314034

Cited By

Cited by

Periodical cited type(9)

1.	曲振廷，叶关毅，李环，徐小磊，李素芬. 归脾汤加减治疗儿童学习困难型多动症的临床研究. 吉林医药学院学报. 2024(03): 200-203 .
2.	张倩，刘广华，何月敏，谢晓颖，徐乐瑶. 整合心理行为干预对多动症患儿认知功能及P300的影响. 中国基层医药. 2024(06): 885-889 .
3.	苑成浩，杨丽，李明，刘晓亮. 调神益智汤联合生物反馈对学龄期多动症患儿血清ACTH、CORT水平的影响. 四川中医. 2024(07): 129-132 .
4.	钦云峰，凌寅杰，袁琛. 脑蛋白水解物联合盐酸托莫西汀治疗小儿多动症的效果观察及对患儿认知功能的影响. 中国妇幼保健. 2024(17): 3327-3331 .
5.	巫慧敏，任妍，朱帝玲，陈月，张素华，秦成洁，罗映娟，杨柳. 四川省成都市42679名学龄前儿童中注意缺陷多动障碍现状调研及影响因素分析. 实用临床医药杂志. 2023(08): 62-66 . 本站查看
6.	赵云鹏，白光磊，梁力泳. 自拟清心补气平肝汤联合盐酸托莫西汀治疗注意缺陷多动障碍的临床研究. 国际中医中药杂志. 2023(06): 684-688 .
7.	张雪宁，谢振中，庞玉兰. 注意缺陷多动障碍患儿肠道细菌构成特点及临床意义. 中国妇幼保健. 2023(14): 2593-2596 .
8.	李辉. 不同严重程度多动症儿童的血清NE和DA水平及其影响因素分析. 中国处方药. 2023(10): 169-171 .
9.	徐晓慧. 分析3～10岁儿童注意缺陷多动症状的发生状况及其与睡眠的关系. 世界睡眠医学杂志. 2023(10): 2350-2352 .

Other cited types(3)

Get Citation

PDF

XML

Article views (104) PDF downloads (5) Cited by(12)

Turn off MathJax

Article Contents

Abstract

References

Value of plasma neutrophil extracellular traps on illness condition and prognosis in patients with acute cerebral infarction